N-(1-Benzyl-pyrrolidin-3-yl)-2-chloro-N-ethyl-acetaMide
|
- $1378
- Product name: N-(1-Benzyl-pyrrolidin-3-yl)-2-chloro-N-ethyl-acetaMide
- CAS: 1353952-82-5
- MF: C15H21ClN2O
- MW: 280.79
- EINECS:
- MDL Number:MFCD21093585
- Synonyms:N-(1-Benzyl-pyrrolidin-3-yl)-2-chloro-N-ethyl-acetaMide;Acetamide, 2-chloro-N-ethyl-N-[1-(phenylmethyl)-3-pyrrolidinyl]-
4 prices
Selected condition:
Brand
- Chemenu
- Crysdot
Package
- 1g
- ManufacturerChemenu
- Product numberCM496705
- Product descriptionN-(1-Benzylpyrrolidin-3-yl)-2-chloro-N-ethylacetamide 97%
- Packaging1g
- Price$1378
- Updated2026-05-26
- Buy
- ManufacturerChemenu
- Product numberCM496705
- Product descriptionN-(1-Benzylpyrrolidin-3-yl)-2-chloro-N-ethylacetamide 97%
- Packaging1g
- Price$1378
- Updated2026-05-20
- Buy
- ManufacturerCrysdot
- Product numberCD11286417
- Product descriptionN-(1-Benzylpyrrolidin-3-yl)-2-chloro-N-ethylacetamide 97%
- Packaging1g
- Price$1378
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11286417
- Product descriptionN-(1-Benzylpyrrolidin-3-yl)-2-chloro-N-ethylacetamide 97%
- Packaging1g
- Price$1378
- Updated2026-05-26
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM496705 | N-(1-Benzylpyrrolidin-3-yl)-2-chloro-N-ethylacetamide 97% | 1g | $1378 | 2026-05-26 | Buy |
| Chemenu | CM496705 | N-(1-Benzylpyrrolidin-3-yl)-2-chloro-N-ethylacetamide 97% | 1g | $1378 | 2026-05-20 | Buy |
| Crysdot | CD11286417 | N-(1-Benzylpyrrolidin-3-yl)-2-chloro-N-ethylacetamide 97% | 1g | $1378 | 2021-12-16 | Buy |
| Crysdot | CD11286417 | N-(1-Benzylpyrrolidin-3-yl)-2-chloro-N-ethylacetamide 97% | 1g | $1378 | 2026-05-26 | Buy |
Properties
Boiling point :395.7±42.0 °C(Predicted)
Density :1.16±0.1 g/cm3(Predicted)
pka :8.37±0.40(Predicted)
Density :1.16±0.1 g/cm3(Predicted)
pka :8.37±0.40(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




